✉news ScienceBiology first seen 1 d ago, last 6 h ago, peak #4
NeoGenesis Capital Launches Fund Targeting Superintelligence and Synthetic Biology
Original: NeoGenesis Capital Launches Fund Focused On Superintelligence And Synthetic Biology
NeoGenesis Capital has announced the launch of a new investment fund focused on two frontier areas: superintelligence and synthetic biology. The firm will back companies working on advanced artificial intelligence and engineered biological technologies. Details on the fund's size, investors, or specific portfolio targets have not been disclosed, and reaction from the tech and biotech communities is still limited.
Why now: Interest in funding vehicles tied to superintelligence and biotech is rising as investors seek exposure to frontier technologies.
Rank over time, top of the chart is #1. 16 snapshots from 1 d ago to 6 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2277438